||Registry of biomedical companies:
[(]  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 454 active entries
270 Kifisias Ave
Phone: +30 210 877 1501
Fax: +30 210 685 9786
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Since its foundation in 1997, GENESIS Pharma has been a leading biopharmaceutical company headquartered in Greece. With its core business activity focusing on the sales, marketing and distribution of biopharmaceutical products, GENESIS Pharma has developed strategic alliances with 13 leading companies in the global biotechnology market, such as Amgen, Biogen Idec, Celgene, Cephalon, Pharmamar, Shire and Vifor.The company has launched and marketed a unique portfolio of innovative biopharmaceutical products in Greece and Cyprus, principally within the specialty therapeutic areas of the Central Nervous System, Haematology, Oncology, Nephrology, Rheumatology and Gastroenterology. Many of the company‘s products treat rare chronic or life-threatening diseases and most of them address previously unmet or underserved clinical needs. GENESIS Pharma S.A. is interested in conducting new partnerships with Biotech companies in the therapeutic areas of expertise and beyond.
Last update of this entry: September 06, 2012